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Abstract 
Leprosy, a chronic mycobacterial infection caused by Mycobacterium leprae, is an infectious disease that has ravaged 
human societies throughout millennia. This ancestral pathogen causes disfiguring cutaneous lesions, peripheral nerve 
injury, ostearticular deformity, limb loss and dysfunction, blindness and stigma. Despite ongoing efforts in interrupt‑
ing leprosy transmission, large numbers of new cases are persistently identified in many endemic areas. Moreover, at 
the time of diagnosis, most newly identified cases have considerable neurologic disability. Many challenges remain 
in our understanding of the epidemiology of leprosy including: (a) the precise mode and route of transmission; (b) 
the socioeconomic, environmental, and behavioral factors that promote its transmission; and (c) strategies to achieve 
early diagnosis and prevent neurologic impairment to reduce the large burden of disability among newly identified 
cases; and among those who endure long‑term disability in spite of completing multidrug therapy.
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Background
Leprosy is a chronic mycobacterial infection caused by 
Mycobacterium leprae leading to a plethora of clinical 
manifestations ranging from cutaneous manifestations 
to disfigurement, deformity, stigma, and disability (neu-
rologic and blindness). The burden of disease associated 
with M. leprae infection in humans stems from the abil-
ity of this bacterial pathogen to induce severe injury of 
peripheral nerves (Schwann cells) and skin (keratinocytes 
and histiocytes) [1–7]. The clinical spectrum of disease of 
leprosy is further defined by the immune response to the 
leprosy bacillus ranging from tuberculoid, to borderline, 
and to lepromatous forms (Ridley-Jopling) [1, 2]. Once 
the infection is established, the occurrence of leprosy 
reactions, because of their inflammatory impact on the 
peripheral nerve, constitutes an important contributor to 
sensory loss and dysfunction [2, 3, 8, 9].
Leprosy trends
Leprosy does not constitute the ancestral plague that 
once used to be. However, the elimination of leprosy as 
a public health problem as defined by the World Health 
Organization, has not been achieved in any meaningful 
and sustainable manner [6, 7]. Besides its measurable 
medical consequences, leprosy hampers the freedoms 
and capabilities of individuals and affected communities 
[10]; and often excludes individuals from social life due 
to the often associated stigma [11–13]. The early tales 
of fear and pity that leprosy in its severe forms elicited 
among many human groups, continues to transpire to a 
similar degree into modern societies [6, 7, 13].
Leprosy continues to be an important infectious dis-
ease in many endemic settings as demonstrated by: (a) 
a growing number of new cases [7, 14, 15]; (b) many 
patients completing multi-drug therapy but subsequently 
developing leprosy reactions [16, 17]; or (c) microbio-
logically treated individuals but with long-term neuro-
logic dysfunction and disability originated by irreversible 
peripheral nerve injury [2, 16].
Since 1981, multi-drug therapy (MDT) has been uni-
versally instituted through active case finding in highly 
affected communities [6, 14]. These programs have 
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achieved some degree of success by decreasing the preva-
lence of the disease [14], however, there are many contin-
uing challenges including: (a) yearly, new cases continue 
to be detected in highly endemic areas [7]; (b) since 2005, 
the number of reported new cases has remained consist-
ently stable despite continuous use of MDT concomi-
tantly with a substantial decrease in the prevalence of the 
disease [7]; (c) a rising number of new cases are expected 
to reach the 4 million mark by the year 2020 [7]; and (d) 
From 2007 to 2013, new cases continue to be identified 
with grade 2 disability with no evidence of this indicator 
decreasing [7].
There are two major potential reasons for the persis-
tent detection of new cases of leprosy in endemic areas. 
The first one is that the “elimination phase” has transi-
tioned into an era of complacency [6, 7, 14]. The reported 
rate of new case detections suggests that the rate of new 
cases decreased by 60  % from 2000 to 2005 [7]. How-
ever, there is evidence to suggest that the detection of 
cases did not truly decreased to such degree during this 
period; and that current reports may actually represent 
an underestimation of newly detected cases [7]. Sec-
ondly, persistent transmission of M. leprae calls for reas-
sessing our long-held notions about its mechanism and 
routes of transmission [18–20]. Current epidemiologic 
trends reinforce old disagreements regarding the portal 
of entry and the pathways of M. leprae into the human 
body [19, 20]. Neither person-to-person transmission 
nor host-susceptibility explains the patchy distribution 
of leprosy, and new cases are detected in persons who 
have had no know contact with human leprosy (30–60 % 
of cases) [5, 6]. Transmission of leprosy to close contacts 
has been documented and it is considered a major risk 
factor for developing leprosy among susceptible individ-
uals [21–23]. Nonetheless, the precise mode and route of 
transmission has not been satisfactorily defined [22, 23]. 
It has been assumed that person-to-person transmission 
occurs by nasal secretions or cutaneous lesions under 
circumstances such as overcrowding, inadequate housing 
and lack of hygiene [21–23].
There is sufficient ecological data to suggest that the 
transmission of leprosy is potentially influenced by envi-
ronmental factors such as soil and water exposures, 
insect vectors playing a role [24–35], and the free-living 
amoebas (e.g., Acanthamoeba spp.) may participate in 
the environmental viability of leprosy in some biotopes 
[30, 31]. Zoonotic transmission from natural infection 
of armadillos in the Southeast United States has been 
confirmed as responsible for the majority of autochtho-
nous transmission of cases in this area [32]. It is likely 
that armadillos may also play an important role in the 
transmission of leprosy in some areas of Latin America 
such as in Colombia, Venezuela, Mexico, and Brazil [33]. 
Understanding how environmental factors influence 
host-pathogen interactions in complex natural systems 
[34, 35], where multiple feedbacks between biotic and 
abiotic factors take place, is especially important in the 
context of environmentally persistent pathogens such as 
M. leprae.
Human migration and the spread of Mycobacterium 
leprae
The mycobacterial ancestor of M. leprae diverged from 
the tuberculosis bacilli approximately 66 million years 
ago, long before the origin of the Homo genus [36–42]. 
Estimates of the intracellular adaptation of M. leprae 
related to reductive evolution and pseudogene develop-
ment has been estimated to occur around 9 million years 
ago [37, 38]. Our current understanding based on recent 
genetic and molecular clock data indicates that leprosy 
the human species prior or during the Paleolithic [37]. 
In turn, human migration has been crucial in the global 
spread of leprosy [38]. In this evolutionary journey, M. 
leprae has migrated with human populations through 
expeditionary, military, colonialist, and other human 
endeavours [38–41]. The earliest clinical descriptions of 
leprosy are said to be from Egypt and India from records 
dating back to 600 B.C.E [38]. Older descriptions of dis-
figuring cutaneous illnesses possibly including leprosy 
under the Hebrew Tsar’ath (zarath) contained in the Old 
Testament; however, this fact remains controversial since 
there is scant skeletal evidence for leprosy in human 
remains from Israel [13]. Humans are natural reservoirs 
in the transmission of M. leprae and therefore the global 
spread of leprosy is tied to historical milestones of human 
migration [10, 37–39]. Recent comparative genomic evi-
dence points to the origin of the leprosy in Eastern Africa 
[38, 39]. The cohabitation of M leprae with human hosts 
has provided M. leprae with different social and biologi-
cal attributes that facilitated the selection of different 
traits conferring different adaptive biological properties 
[37–39]. Phyleogeographic studies have demonstrated an 
association between the spread of leprosy and migration 
patterns of earlier human societies and trade routes (i.e., 
the Silk Road that united Europe to China contributed 
to the spread of leprosy) [38, 39, 41, 43]; or to histori-
cal events corresponding to the returning expeditionary 
forces of antiquity spreading the pathogen from the Mid-
dle-Eastern strain of M. leprae to Medieval Europe [38]. 
Subsequently, European explorers spread the disease 
westward to the New World or through the Atlantic slave 
route [37, 39]. Overall, genomic comparisons of ancient 
and modern strains of M. leprae remain remarkably simi-
lar, indicating it was probably improvements in social 
conditions that led to a substantial reduction of leprosy 
in Europe in the 16th Century [40, 41]. While these 
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events indicate the crucial role of humans as reservoirs 
of disease and potentially transmitting to their close con-
tacts, it is also feasible that nasal discharges or cutaneous 
lesions of populations migrating into previously leprosy-
free biotopes may have caused a spillover of M. leprae 
into environmental niches with optimal biotic and abiotic 
factors that subsequently amplified the cycle of transmis-
sion of leprosy.
In modern times, it is likely that the clustering of cases 
of leprosy occurs among individuals living in resource-
poor areas with favorable ecological niches for M. leprae 
to thrive [21–23]. In turn, the human host acquires M. 
leprae by an increased exposure to mycobacteria by their 
low socioeconomic standing combined with their bio-
logic susceptibility to acquire the infection and develop 
the disease. In these settings, poverty operates by pro-
moting low schooling, poor housing in often-unstruc-
tured settlements with overcrowding, lack safe water, 
absence of water management systems and sewage, 
and, as a result most experience poor hygienic practices 
[21–23]. Additionally, most individuals who have been 
diagnosed with leprosy have also experienced food short-
ages and malnutrition. Suffering from leprosy and other 
neglected tropical diseases becomes part of their biologi-
cal destiny and their way of life. Therefore, it is important 
to consider the larger social drivers that underlie the une-
qual distribution of life choices of individuals living in the 
highest endemic areas that place them at risk of suffering 
from leprosy and other neglected diseases.
Mycobacterial ecology
Humanity is irremediably imbedded in a matrix of nat-
ural and man-made ecologies of living organisms [44]. 
Mycobacteria are ubiquitous microorganisms that live in 
natural waters, soils, and engineered water systems that 
have role in nutrient cycling. A major determinant of the 
ecology and epidemiology of mycobacterial species is the 
presence of a lipid-rich outer membrane leading to bio-
film formation, antibiotic/disinfectant resistance, aero-
solization, and surface adherence [20, 44]. A few species 
have evolved from this environmental pools to become 
major human pathogens such as M. tuberculosis, M. lep-
rae and M. ulcerans [13, 45–49]. Searching for common 
ecological patterns and transmission dynamics among 
these three closely phylogenetically related species may 
assist in identifying environmental sources of persistent 
infection [45–49]. For the two major human pathogens, 
M. tuberculosis and M. leprae, it is crucial to adapt to the 
intracellular lifestyle and to modulate the lipid metabo-
lism of sanctuary cells [44] (Table 1). M. tuberculosis and 
M. leprae have evolved pathogenic mechanisms through 
complex evolutionary negotiations between these path-
ogens and their hosts, while the acquisition of a large 
plasmid encoding the toxin mycolactone relates to the 
underlying mechanism of pathogenicity of M. ulcerans 
[48–50]. This mycobacterial pathogen is causative agent 
of Buruli ulcer, which is a chronic destructive necrotizing 
infection of subcutaneous tissue that has been reported 
to occur in more than 30 countries [48–50]. In contrast 
to M. tuberculosis and M. leprae, M. ulcerans adaptation 
mechanisms have involved the selection of certain genes 
that facilitate its livelihood occupying aquatic aerobic, 
dark, and osmotically stable environments and its ability 
to reside in the extracellular matrix of the subcutaneous 
tissues where it unleashes the production of its toxin [50]. 
Genetic analyses of M. ulcerans have shown that it had a 
common ancestor with M. marinum and that it diverged 
around a million years ago [45, 49, 50]. M. marinum pro-
duces a relatively milder nodular cutaneous lesions com-
pared with Buruli ulcer [50].
Proverbial human-to-human transmission via respira-
tory droplets of M. leprae infection has been traditionally 
considered the driving engine of transmission of leprosy 
[18, 19, 51, 52]. While leprosy bacilli are present in the 
nasopharynx of individuals with multibacillary leprosy 
[51] and from cutaneous lesions [52], and that these 
bacilli are able to infect other susceptible human hosts 
[18, 19], the precise mechanism and route of transmis-
sion remain to be completely elucidated. Indeed, the 
current epidemiology of the persistent transmission of 
leprosy along with collected evidence made since the 
19th Century suggest that environmental factors such 
as soil and water, vegetation, arthropods [20], free-living 
amoebas [30, 31], and animal reservoir host such as the 
nine-banded armadillo (Dasypus novemcintus) play an 
influential role in the ongoing transmission of M. leprae 
[32, 33].
In 1895, Hansen and Looft made the initial observa-
tion regarding the possibility of environmental factors 
involved in the transmission of leprosy [24]. They sug-
gested that the initial site of cutaneous lesions often 
involved sites with direct contact with environmental 
surfaces (e.g., wading in streams and rivers in patients 
with lesions in calves). Subsequently, 27  years after 
Hansen’s description of M. leprae, Sand proposed that 
the transmission of leprosy between humans takes place 
indirectly. His findings were the result of analyzing 1221 
patients in the Norwegian leprosarium of Reitgjaerdet in 
whom the transmission within household was relatively 
low and most cases occurred in men who had more con-
tact with environmental sources. He further proposed 
that perhaps a living organism or ground containing 
decomposing material were factors involved in the trans-
mission cycle [25].
Environmental factors such as climate, type of soil and 
water, environmental degree of acidity [20], etc.; along 
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with spillover of M. leprae from human cases (e.g., nasal 
discharges contaminating soil or water) may facilitate the 
amplification of the transmission cycle in biotopes with 
existing suitable ecological abiotic and biotic determi-
nants (i.e., tropical and subtropical settings) [34, 35]. In 
this hypothetical model, we can postulate that chemo-
prophylaxis (or preemptive treatment) of contacts of 
multibacillary cases and effective treatment of leprosy 
cases decreases spillage of M. leprae into environmental 
reservoirs (soil, water, plants, or free-living amoebas) [24, 
25, 27]. Preliminary evidence from a leprosy-endemic 
area in India has shown that genetic material of M. lep-
rae was detected near washing and bathing areas where 
cases of leprosy were detected and genetic fingerprinting 
correlated between human cases and DNA detected in 
soil samples [24, 29]. The spillover of M. leprae into soil 
and water may explain the acquisition of this pathogen 
by armadillos acting as scavengers, and ultimately link-
ing a reverse cycle of transmission from armadillos back 
to humans [32]. Nevertheless, it is possible that there are 
other unidentified environmental reservoirs or vectors 
influencing the occurrence of new human infections in 
highly endemic areas. Zoonotic transmission of M. leprae 
from armadillos in the Golf Coast of the United States 
contributes to endemic human infections detected in this 
geographic area every year, supporting the fact that lep-
rosy is not exclusively transmitted person-to-person [32].
Free‑living amoebas as environmental sanctuaries 
of M. leprae
There is some evidence that the obligate intracellular M. 
leprae may spill over onto environmental niches and sur-
vive endosymbiotically inside free-living amoebae similar 
to the mechanism described of Legionella pneumophila 
residing inside Acanthamoeba [30, 31]. Large numbers of 
viable leprosy bacilli are expelled into the environment in 
the nasal secretions or to a lower degree from skin lesions 
of individuals diagnosed with multibacillary leprosy [52]. 
There is also evidence that M. leprae may invade and 
infect the nasal mucosa or into abraded/punctured skin 
[52–54]. In this regard, it is feasible that free-living path-
ogenic amoebae potentially act as “external” reservoirs 
capable of ingesting and supporting the environmental 
viability of M. leprae expelled by infectious patients into 
the environment and thus acting as a macrophage-like 
niches [30, 31]. Further evidence has demonstrated that 
M. leprae remains viable for prolonged periods inside 
Acanthamoeba castellani and Acanthamoeba polyphaga; 
and it is able to survive encystment and retain infectivity 
in the nu/nu mouse model [33]. It remains to be tested if 
M. leprae infected amoebae is able to transport the bacilli 
through nasal mucosa or through intact or abraded skin 
to produce clinical disease [31].
Arthropods as vectors of M. leprae transmission
The possibility of arthropods as vectors of M. leprae has 
not been conclusively ruled out [5]. As early as 1915, 
Adolpho Lutz suggested that “the erratic manner of the 
propagation of leprosy” might be explained by the bites 
of biting arthropods, particularly of Culex mosquitoes 
(i.e., Culex fatigans) [20]. In fact, there are several biting 
arthropods residing in highly endemic areas of leprosy 
that theoretically might act as a vector of M. leprae [55–
66]. In some studies, the distribution of single lesions of 
tuberculoid leprosy correlated with exposed skin areas 
[60, 61]. Mechanical studies have demonstrated the feasi-
bility of biting arthropods to uptake M. leprae since large 
numbers of bacilli are readily available within cutaneous 
lesions to the biting apparatus of many species of arthro-
pods among individuals with untreated multibacillary 
leprosy [59, 61–66]. Additionally, it has been shown that 
patients with lepromatous leprosy by developing bactere-
mia may make viable bacilli available to biting arthropods 
[63–65]. Sandflies have been ruled out as vectors of lep-
rosy transmission [66].
There is evidence that mycobacterial species constitut-
ing the Mycobacterium tuberculosis complex (i.e., M. can-
etti) infected humans before the Neolithic period (< than 
12,000 years ago) and that a non-mammalian vector may 
have played a role (e.g., plants or insects) [44–46]. Tuber-
culosis infection later spread to dairy animals as a result 
of human transmission during their domestication and 
involving a mechanism of transmission either through 
direct contact or through an unrecognized vector [44].
Mycobacterium ulcerans transmission cycle involves 
aquatic insect vectors, aquatic plants, and aquatic ani-
mals [45, 47–50]. Similarly, survival of M leprae in envi-
ronmental niches may also involve natural reservoirs 
(e.g., free-living amoebas) or it may be transmitted by 
arthropods (e.g., mosquitoes). It is also possible that spe-
cies of the Mycobacterium tuberculosis complex may 
use environmental sanctuaries such as free-living amoe-
bas to resist the external environment by acting as a 
macrophage-like niche [20]. Further studies using novel 
molecular assays need to be conducted to assess the 
potential contribution of arthropods to the transmission 
of leprosy in endemic areas.
Early diagnosis and neurologic disability
Peripheral nerve involvement occurs in all patients with 
M. leprae infection. At the time of a diagnosis of lep-
rosy, up to 60  % of cases have evidence of peripheral 
nerve damage enough to require prolonged course of 
corticosteroids [6]. Neural tropism of the leprosy bacil-
lus is through its binding and entry into Schwann cells 
causing demyelination [8, 9, 67–69]. These events results 
in demyelination of myelinated Schwann cells that 
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manifests clinically with decreased sensorimotor func-
tion and its associated complications [69, 70]. Addi-
tionally, M. leprae leads to a dedifferentiation process 
of Schwann cells transforming them into Trojan horses 
for the systemic dissemination of the bacilli [3, 69, 70]. 
Peripheral nerve sensorimotor dysfunction in patients 
with leprosy is frequently exacerbated by episodes of 
leprosy reactions [8, 9]. Indeed, even after effective anti-
bacterial therapy, a large number of dead bacterial cells 
remain within nerves and continue to elicit immuno-
logic responses manifested as acute or chronic neuritis 
[8, 71]. Early detection and treatment of neuropathy in 
leprosy has important preventive potential. Preventing 
leprosy reactions or effectively treating them is therefore 
an important consideration in any strategy attempting to 
reduce peripheral nerve injury. We need to expand our 
understanding of factors that predispose individuals to 
develop leprosy reactions and the mechanisms that trig-
ger their occurrence. One important consideration is 
the potential role of the microbiome in modulating the 
inflammatory response, particularly of herpes viruses 
[2]. While there is little research in this area, there is 
ample evidence in other clinical scenarios to illustrate 
that herpes viruses modulate inflammatory responses 
during pathologic conditions [72] (Table  2). Early iden-
tification of leprosy cases remains a central priority in 
controlling this disease. In this regard, school-screening 
programs employing clinical assessments combined with 
serological and molecular surveys in endemic areas have 
been shown to increase the early detection of cases [73]. 
These programs have the greatest potential for reduc-
ing transmission by early instituting of treatment early 
in the course of the disease; and by identifying house-
hold contacts and household cases. Similarly, geospatial 
analyses of risk assessments of leprosy based on thermal 
and hydrological environments have demonstrated useful 
in predicting clustering of cases in studies conducted in 
Ethiopia and India [34, 35] (Table 2). Efforts to scale up 
school-based screenings and geospatial risk assessments 
based on ecological determinants in hyperendemic set-
tings may offer so far, the best opportunity to reduce the 
occurrence of new cases.
Conclusions
Our understanding of the transmission dynamics of M. 
leprae is incomplete. While person-to-person transmis-
sion may play a role, there is a possibility of other modes 
of transmission involved. Therefore, there is a need 
for a fresh reexamination of the historical, phyleogeo-
graphic, sociocultural, and environmental factors linked 
to the spread of M. leprae among human populations. 
We need to consider mycobacterial ecologies of other 
pathogenic mycobacteria such as M. ulcerans; and to 
expand our exploration for environmental determinants 
including thermal-hydrological factors (i.e., soil, vegeta-
tion, water); intermediate reservoirs or vectors including 
free-living amoebas, arthropods, and zoonotic transmis-
sion. Identifying epidemiologic clues from these analyses 
may facilitate designing effective control or elimination 
interventions.
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